The activation of TLR2 in the brains of PD patients, results in elevated levels of pro-inflammatory cytokines and the migration of microglia along with intensification of neuroinflammation combined with elevated production of α-synuclein (20) (Figure 3). The gene discussed is SNCA; the disease is Parkinson disease.